市場調查報告書
商品編碼
1470516
診斷心電圖機市場:按產品類型、引線類型和最終用戶 - 2024-2030 年全球預測Diagnostic Electrocardiograph Market by Product (Devices, Software & Services), Lead Type (12-lead, 3-lead, 5-lead), End User - Global Forecast 2024-2030 |
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
預計2023年診斷心電圖機市場規模為112億美元,預計2024年將達119.5億美元,2030年將達176.1億美元,複合年成長率為6.67%。
診斷心電圖機是一種非侵入性的重要醫療設備,用於檢測和監測與心臟相關的疾病和狀況。該設備也稱為心電圖或心電圖,透過放置在皮膚上的電極記錄一段時間內心臟的電活動。在全球範圍內,這些設備被用於醫院、診所和其他醫療機構,並且擴大用於遠端患者監護醫療保健領域快速成長的趨勢。心血管疾病的日益普及、診斷技術的進步以及遠端患者監護的興起推動了市場擴張。但面臨心電圖機價格高、診斷設備報銷政策不足等挑戰。診斷心電圖機市場的未來成長機會在於透過人工智慧和機器學習的新應用擴大採用數位健康技術。
主要市場統計 | |
---|---|
基準年[2023] | 112億美元 |
預測年份 [2024] | 119.5億美元 |
預測年份 [2030] | 176.1億美元 |
複合年成長率(%) | 6.67% |
增加產品軟體和服務的使用、資料分析和準確解釋
心臟事件記錄器是一種用於短期心臟監測的可攜式設備,可捕捉特定事件或症狀。心電圖監測是一種連續門診設備,可記錄較長時間(通常 24 至 48 小時)內的心臟活動。植入式循環記錄器是一種皮下裝置,植入後用於長期監測,特別是檢測心律不整。行動心電遙測設備是能夠即時傳輸心臟資料的無線設備,可在傳統環境之外進行連續監測。靜態心電圖設備是用於常規、無壓力評估的標準心電圖設備。智慧心電圖監視器整合了智慧技術,以增強連接性、資料分析和用戶互動。壓力心電圖設備旨在監測身體壓力測試期間的心臟活動。診斷心電圖領域包括一套軟體和服務。其中包括資料分析、解釋演算法和遠端醫療解決方案,可增強上述設備的診斷能力。這些產品共同建構了一種全面的診斷方法,將分析工具和服務與硬體創新相結合,以更好地了解心臟健康。
導極類型:越來越偏好12 導程心電圖儀,它可以提供最詳細的診斷
12 導程心電圖儀通常被視為標準,因為其全面的範圍可從 12 個不同角度提供心臟概況。特別是,它可以早期診斷心肌梗塞等心臟疾病,強烈建議在急診醫院使用。三導聯心電圖通常用於在醫院病房和社區長期監測患者。由於簧片數量有限,只能觀察到基本的節奏。然而,它足以檢測嚴重的、危及生命的心律不整。 5導聯心電圖比3導程心電圖提供更全面的訊息,使其適合重症患者和可能快速變化的緊急照護。這種引線結構可以監測節律和缺血。 6 導程心電圖比 5 導程心電圖稍微專業一些,通常用於需要快速詳細了解心臟電活動的緊急情況。單導聯心電圖主要用於初步心律辨識和長期心率監測。單導聯心電圖通常用於在醫生辦公室、門診或患者家中進行長期監測。
最終用戶:隨著加護病房和心臟科病房的增加,診斷心電圖儀在整個醫院和診所的潛力不斷增加。
門診手術中心 (ASC) 在醫療保健行業中發揮著至關重要的作用。由於與醫院相比,這些中心方便且成本較低,因此對門診手術的高需求推動了這些中心的發展。隨著 ASC 數量的增加,對包括心電圖機在內的高階、精確診斷設備的需求也在增加。診斷中心主要著重於疾病檢測和預防。在這種環境中,高精度和快速結果至關重要。對遠距心臟病學等方面的需求也為心電圖市場提供了上升動力。醫院和診所佔據了最終用戶心電圖市場的主要佔有率。加護病房、心臟科室和其他經常收治心臟病患者的醫療部門清楚地表明在這些環境中需要心電圖設備。
區域洞察
憑藉技術創新和機遇,美洲診斷心電圖機市場預計在未來幾年將顯著成長。完善的醫療保健政策、對非侵入性技術不斷成長的需求以及心電圖機技術的持續進步使該地區成為強大的市場力量。由於對先進診斷工具的需求不斷成長、人口成長和健康意識不斷提高,歐洲、中東和非洲地區的心電圖機市場正在成長勢頭。歐洲強大的醫療保健部門在先進的疾病管理通訊協定的支持下,正在推動對包括心電圖機在內的準確診斷設備的需求。儘管中東和非洲市場仍處於起步階段,但預計將快速成長,這主要得益於醫療基礎設施的改善以及政府對醫療數位化介入的加強。亞太地區(APAC),尤其是快速成長的印度和中國,由於其龐大的患者基礎和不斷成長的醫療保健支出,正在為診斷心電圖市場創造利潤豐厚的機會。此外,心血管疾病的盛行率不斷上升以及對先進醫療設備的大力投資是促成這一轉變的特徵因素。
FPNV定位矩陣
FPNV定位矩陣對於評估診斷心電圖機市場至關重要。我們檢視與業務策略和產品滿意度相關的關鍵指標,以對供應商進行全面評估。這種深入的分析使用戶能夠根據自己的要求做出明智的決策。根據評估,供應商被分為四個成功程度不同的像限:前沿(F)、探路者(P)、利基(N)和重要(V)。
市場佔有率分析
市場佔有率分析是一種綜合工具,可以對診斷心電圖機市場供應商的現狀進行深入而深入的研究。全面比較和分析供應商在整體收益、基本客群和其他關鍵指標方面的貢獻,以便更好地了解公司的績效及其在爭奪市場佔有率時面臨的挑戰。此外,該分析還提供了對該行業競爭特徵的寶貴見解,包括在研究基準年觀察到的累積、分散主導地位和合併特徵等因素。詳細程度的提高使供應商能夠做出更明智的決策並制定有效的策略,從而在市場上獲得競爭優勢。
1. 市場滲透率:提供有關主要企業所服務的市場的全面資訊。
2. 市場開拓:我們深入研究利潤豐厚的新興市場,並分析其在成熟細分市場的滲透率。
3. 市場多元化:提供有關新產品發布、開拓地區、最新發展和投資的詳細資訊。
4.競爭評估與資訊:對主要企業的市場佔有率、策略、產品、認證、監管狀況、專利狀況、製造能力等進行全面評估。
5. 產品開發與創新:提供對未來技術、研發活動和突破性產品開發的見解。
1.診斷心電圖機市場規模及預測為何?
2.診斷心電圖機市場預測期間需要考慮投資的產品、細分市場、應用和領域有哪些?
3.診斷心電圖機市場的技術趨勢和法規結構是什麼?
4.診斷心電圖機市場主要廠商的市場佔有率是多少?
5.進入診斷心電圖市場的合適型態和策略手段是什麼?
[191 Pages Report] The Diagnostic Electrocardiograph Market size was estimated at USD 11.20 billion in 2023 and expected to reach USD 11.95 billion in 2024, at a CAGR 6.67% to reach USD 17.61 billion by 2030.
A diagnostic electrocardiograph is a non-invasive, essential medical device used in detecting and monitoring heart-related diseases and conditions. Also referred to as an ECG or EKG, this device records the electrical activity of the heart over a period of time through electrodes attached to the skin. Globally, these devices are used in hospitals, clinics, and other healthcare facilities, with increased use in remote patient monitoring, a burgeoning trend in healthcare. Market expansion is propelled by the growing prevalence of cardiovascular ailments, advances in diagnostic technology, and the rise of remote patient monitoring. However, it faces challenges owing to the high cost of electrocardiographs and inadequate reimbursement policies for diagnostic devices. Future growth opportunities for the diagnostic electrocardiograph market lie in the growing adoption of digital health technology with the emerging applications of artificial intelligence and machine learning.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 11.20 billion |
Estimated Year [2024] | USD 11.95 billion |
Forecast Year [2030] | USD 17.61 billion |
CAGR (%) | 6.67% |
Product: Growing utilization of software & services or data analysis and accurate interpretation
Event monitors are portable devices for short-term cardiac monitoring, capturing specific events or symptoms. Holter monitors are continuous ambulatory devices recording heart activity over an extended period, typically 24 to 48 hours. Implantable loop recorders are subcutaneous devices implanted for long-term monitoring, especially for detecting irregular heart rhythms. Mobile cardiac telemetry devices are wireless devices that enable real-time transmission of cardiac data, providing continuous monitoring outside traditional settings. Resting ECG devices are standard electrocardiogram devices used for routine, non-stressful assessments. Smart ECG monitors integrate smart technology for enhanced connectivity, data analysis, and user interaction. Stress ECG devices are designed to monitor heart activity during physical stress tests. The diagnostic electrocardiography landscape includes a suite of software & services. These encompass data analysis, interpretation algorithms, and telemedicine solutions, enhancing the diagnostic capabilities of the devices mentioned above. Together, these products contribute to a comprehensive diagnostic approach, combining hardware innovation with analytical tools & services for a more nuanced understanding of cardiac health.
Lead Type: Growing preference for 12-lead electrocardiograph as it provides the most detailed diagnostics
The 12-lead electrocardiograph is often considered the standard as its comprehensive range offers an overview of the heart from 12 different angles. Highly recommended for acute hospital settings, it allows for early diagnosis of heart conditions, particularly myocardial infarction. The 3-lead ECG is typically utilized for monitoring patients over a prolonged timespan, often on wards or in the community. Due to the limited number of leads, only basic rhythm can be observed. However, it is sufficient for detecting any major life-threatening arrhythmias. The 5-lead ECG provides more comprehensive information than the 3-lead, making it preferred for critical care and emergency settings where rapid changes can occur. This lead structure enables monitoring of both rhythm and ischemia. The 6-lead ECG is slightly more specific than the 5-lead and is generally used in emergency situations where a quick but detailed overview of the heart's electrical activity is needed. Single-lead ECGs are primarily used for preliminary rhythm identification or long-term heart rate monitoring. They are often found in doctor's offices, outpatient settings, or patient's homes for long-term monitoring.
End-User: Increasing potential of diagnostic electrocardiographs across hospitals & clinics with increased intensive care units and cardiac units
Ambulatory surgical centers (ASCs) play a pivotal role in the healthcare industry. These centers are driven by a high demand for outpatient surgeries, given their convenience and lower cost compared to hospitals. As the number of ASCs proliferates, there is a growing requirement for high-end, precise diagnostic equipment, including Electrocardiographs. Diagnostic centers mainly revolve around disease detection and prevention. High accuracy and quick results are paramount in this setting. The need for facets, including telecardiology, has also given the ECG market an upward thrust. Hospitals & clinics form the major share of the end-user ECG market segment. The palpable necessity for ECG devices in these settings is driven by the intensive care units, cardiac units, and other medical departments that routinely cater to heart patients.
Regional Insights
Blended with innovation and lucrative opportunities, the diagnostic electrocardiograph market in the Americas is expected to grow substantially in the coming years. With the advent of crafted healthcare policies coupled with increased demand for non-invasive techniques and continuous technological advancements in electrocardiographs, this region holds a robust market stronghold. The Electrocardiograph market in the EMEA is gaining momentum, with the region's increasing demand for advanced diagnostic tools, growing population, and rising health awareness. Europe's strong healthcare sector, paved by advanced disease management protocols, is driving the demand for accurate diagnostic devices including electrocardiographs. The markets in the Middle East and Africa are at a nascent stage but are expected to burgeon, primarily owing to the improving healthcare infrastructure and increased government intervention in healthcare digitalization. The Asia-Pacific (APAC) region, particularly the fast-growing economies of India and China, is creating lucrative opportunities for the diagnostic electrocardiograph market, with their vast patient base and increasing healthcare spending. Furthermore, the increasing prevalence of cardiovascular diseases coupled with the robust investment in advanced medical equipment are distinctive factors that are contributing to this upturn.
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Diagnostic Electrocardiograph Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Diagnostic Electrocardiograph Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Diagnostic Electrocardiograph Market, highlighting leading vendors and their innovative profiles. These include ACS Diagnostics, AliveCor, Inc., Ambu A/S, Aspel SA, ATsens Co., Ltd., Auxo Medical LLC, Bionet Co., Inc., BPL Medical Technologies Pvt. Ltd., BTL, Cardioline S.p.A., CompuMed, Inc., Custo Med GmbH, Davis Medical Electronics, Inc., Edan Instruments, Inc., Fukuda Denshi Co., Ltd., GE HealthCare Technologies Inc., Hill-Rom, Inc., Innomed Medical Zrt., Koninklijke Philips N.V., Lepu Medical Technology(Beijing)Co.,Ltd., Nihon Kohden Corporation, Norav Medical Ltd., OSI Systems, Inc., Schiller AG, Shenzhen Comen Medical Instruments Co., Ltd., Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Suzuken Co., Ltd., Vectracor, Inc., Viatom Technology Co., Ltd., VYAIRE Medical, Inc., and Zimmer MedizinSysteme GmbH.
Market Segmentation & Coverage
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
1. What is the market size and forecast of the Diagnostic Electrocardiograph Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Diagnostic Electrocardiograph Market?
3. What are the technology trends and regulatory frameworks in the Diagnostic Electrocardiograph Market?
4. What is the market share of the leading vendors in the Diagnostic Electrocardiograph Market?
5. Which modes and strategic moves are suitable for entering the Diagnostic Electrocardiograph Market?